Pragmin Prognosis entered into a definitive agreement to acquire CYNOGEN Inc. from Rosetta Genomics Ltd. (NasdaqCM:ROSG) for $2.9 million on September 8, 2017. Under the terms of deal, Pragmin will pay $1.3 million in cash at closing and balance of the payments to be made over various time intervals in cash. Deal is expected to close within the next several weeks. Pragmin Prognosis cancelled the acquisition of CYNOGEN Inc. from Rosetta Genomics Ltd. (NasdaqCM:ROSG) on October 16, 2017. Pragmin failed to comply with its unconditional obligation to complete the transaction.